Featured Posts
Stand Up To Cancer and St. Baldrick’s Pediatric Cancer Dream Team Announced
The announcement of the Stand Up to Cancer and St. Baldrick’s pediatric cancer dream team brings great excitement and promise. The $14.5 million dollar grant was announced yesterday and awarded to Dr. J.M. Maris (CHOP) and Dr. C.L. Mackall (NCI) to pursue their work in the area of “Immunogenomics to Create New Therapies for High-Risk Childhood Cancers”.
This work will combine the ...
Weekly Roundup 03/24 …
Researchers say NSAIDs can boost stem cells for transplants for cancer patients
New research suggests that treating patients with non-steroidal anti-inflammatory drugs (NSAIDs) may mobilise more stem cells out of the bone marrow for peripheral blood stem cell collection – in animal studies by as much as four to six times.
CHOP Investigator Sheds Light on Effects of Sequestration on Cancer Research
Peter ...
Charities partner to fund international collaborative research
In a groundbreaking effort to boost transatlantic collaborative efforts to find better treatments for recurrent neuroblastoma, charities Solving Kids’ Cancer (US), Neuroblastoma Alliance UK (UK), and J-A-C-K (UK) have joined forces to form the International Neuroblastoma Research Collaborative (INBRC). Jointly they are seeking to award a grant of up to $500,000 to fund an immunotherapy-based ...
CNCF Parent Education Conference 2013
The 2013 CNCF Parent Education Conference will be held on June 28-30, 2013 at The Westin Lombard Yorktown Center, Lombard, IL. Subsidized hotel rooms are available at a rate of $65/night + tax..
Speakers will be :-
Dr. Timothy Cripe
Dr. Rupert Handgretinger
Dr. Paul Sondel
Dr. Araz Marachelian
Dr. Sam Volchenboum
Dr. Greg Yanik
Dr. Sue Cohn
Dr. Chrystal Louis
Hillary van Glatin Phd
Memorial Sloan-Kettering ...
The Dosing of 13-Cis-Retinoic Acid (Accutane) in Neuroblastoma Therapy
The use of isotretinoin (13-cisRA, Accutane) is one part of a protocol used for the treatment of high-risk neuroblastoma (1). As many neuroblastoma families and patients know, taking this medication can be extremely challenging, especially if a patient is unable to swallow the capsules (2). If this is the case, the 13-cisRA must be extracted from the capsule and either mixed with food to be taken ...
